NIAID Banner Logo Image

Opportunistic Infections Citation List: July 17 - July 30, 2015

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

1. Design, Synthesis and Characterization of Dual Inhibitors against New Targets FaGg4 and HtdX of Mycobacterium tuberculosis. Banerjee, D.R., R. Biswas, A.K. Das, and A. Basak. European Journal of Medicinal Chemistry, 2015. 100: p. 223-234. PMID[26092447].

[PubMed]. OI_0717-073015.


2. Recent Progress in the Drug Development of Coumarin Derivatives as Potent Antituberculosis Agents. Keri, R.S., B.S. Sasidhar, B.M. Nagaraja, and M.A. Santos. European Journal of Medicinal Chemistry, 2015. 100: p. 257-269. PMID[26112067].

[PubMed]. OI_0717-073015.


3. Discovery of Antitubercular 2,4-Diphenyl-1H-imidazoles from Chemical Library Repositioning and Rational Design. Pieroni, M., B. Wan, V. Zuliani, S.G. Franzblau, G. Costantino, and M. Rivara. European Journal of Medicinal Chemistry, 2015. 100: p. 44-49. PMID[26071857].

[PubMed]. OI_0717-073015.


4. Synthesis and Pharmacokinetic Evaluation of Siderophore Biosynthesis Inhibitors for Mycobacterium tuberculosis. Nelson, K.M., K. Viswanathan, S. Dawadi, B.P. Duckworth, H.I. Boshoff, C.E. Barry, 3rd, and C.C. Aldrich. Journal of Medicinal Chemistry, 2015. 58(14): p. 5459-5475. PMID[26110337].

[PubMed]. OI_0717-073015.


5. Cytotoxic Homoisoflavones from the Bulbs of Bellevalia eigii. Alali, F., T. El-Elimat, H. Albataineh, Q. Al-Balas, M. Al-Gharaibeh, J.O. Falkinham, 3rd, W.L. Chen, S.M. Swanson, and N.H. Oberlies. Journal of Natural Products, 2015. 78(7): p. 1708-1715. PMID[26147490].

[PubMed]. OI_0717-073015.

Citations from the ISI Web of Knowledge Listings for O.I.

6. Furan Type Lignans with Antimycobacterial Activity. Baquero, E., W. Quinones, S. Franzblau, F. Torres, R. Archbold, and F. Echeverri. Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas, 2015. 14(3): p. 171-178. ISI[000356863700003].

[WOS]. OI_0717-073015.


7. Optimization and Evaluation of 5-Styryl-oxathiazol-2-one Mycobacterium tuberculosis Proteasome Inhibitors as Potential Antitubercular Agents. Russo, F., J. Gising, L. Akerbladh, A.K. Roos, A. Naworyta, S.L. Mowbray, A. Sokolowski, I. Henderson, T. Alling, M.A. Bailey, M. Files, T. Parish, A. Karlen, and M. Larhed. ChemistryOpen, 2015. 4(3): p. 342-362. ISI[000356820900015].

[WOS]. OI_0717-073015.


8. Structure-Activity Relationships of Neplanocin A Analogues as S-Adenosylhomocysteine Hydrolase Inhibitors and their Antiviral and Antitumor Activities. Chandra, G., Y.W. Moon, Y. Lee, J.Y. Jang, J. Song, A. Nayak, K. Oh, V.A. Mulamoottil, P.K. Sahu, G. Kim, T.S. Chang, M. Noh, S.K. Lee, S. Choi, and L.S. Jeong. Journal of Medicinal Chemistry, 2015. 58(12): p. 5108-5120. ISI[000357139000021].

[WOS]. OI_0717-073015.


9. Evolution of a Thienopyrimidine Antitubercular Relying on Medicinal Chemistry and Metabolomics Insights. Li, S.G., C. Vilcheze, S. Chakraborty, X. Wang, H. Kim, M. Anisetti, S. Ekins, K.Y. Rhee, W.R. Jacobs, and J.S. Freundlich. Tetrahedron Letters, 2015. 56(23): p. 3246-3250. ISI[000356544800068].

[WOS]. OI_0717-073015.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2024